Measuring problem prescription opioid use among patients receiving long-term opioid analgesic treatment: development and evaluation of an algorithm for use in EHR and claims data

References

• Guy GP, Jr., Zhang K, Bohm MK, et al. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(26):697–704.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Fellows B, Ailinani H, et al. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician. 2010;13(5):401–435.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA) [Internet]. Rockville (MD): SAMHSA. Results from the 2013 National Survey on Drug Use and Health: Summary of national findings; 2014 [cited 2017 Nov 1]; Available from: https://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf.
   Google Scholar
• Rudd RA, Seth P, David F, et al. Increases in drug and opioid-involved overdose deaths – United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445–1452.
   PubMed Web of Science ®Google Scholar
• Hirschfield DJ. Trump declares opioid crisis a ‘health emergency’ but requests no funds. New York (NY): The New York Times Company; 2017.
   Google Scholar
• National Academies of Sciences Engineering and Medicine. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. Washington (DC): The National Academies Press; 2017.
   Google Scholar
• Vowles KE, McEntee ML, Julnes PS, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569–576.
   PubMed Web of Science ®Google Scholar
• Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012;15(3):ES67–ES92.
   PubMed Web of Science ®Google Scholar
• Sullivan MD, Edlund MJ, Fan MY, et al. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP Study. Pain. 2010;150(2):332–339.
   PubMed Web of Science ®Google Scholar
• White AG, Birnbaum H, Schiller M. Economic impact of opioid abuse, dependence, and misuse. Am J Pharm Benefits. 2011;3:e59–e70.
   Google Scholar
• White AG, Birnbaum HG, Mareva MN, et al. Direct costs of opioid abuse in an insured population in the United States. J Managed Care Special Pharma. 2005;11(6):469–479.
   PubMedGoogle Scholar
• White AG, Birnbaum HG, Schiller M, et al. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care. 2009;15:897–906.
   PubMed Web of Science ®Google Scholar
• Rice JB, White AG, Birnbaum HG, et al. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med. 2012;13(9):1162–1173.
   PubMed Web of Science ®Google Scholar
• Shei A, Rice JB, Kirson NY, et al. Sources of prescription opioids among diagnosed opioid abusers. Curr Med Res Opin. 2015;31(4):779–784.
   PubMed Web of Science ®Google Scholar
• Shei A, Rice JB, Kirson NY, et al. Characteristics of high-cost patients diagnosed with opioid abuse. J Managed Care Special Pharma. 2015;21(10):902–912.
   PubMed Web of Science ®Google Scholar
• Rowe C, Vittinghoff E, Santos GM, et al. Performance measures of diagnostic codes for detecting opioid overdose in the emergency department. Acad Emerg Med. 2017;24(4):475–483.
   PubMed Web of Science ®Google Scholar
• Carrell DS, Cronkite D, Palmer RE, et al. Using natural language processing to identify problem usage of prescription opioids. Int J Med Inform. 2015;84(12):1057–1064.
   PubMed Web of Science ®Google Scholar
• United States Food and Drug Administration [Internet]. Silver Spring (MD): FDA. New safety measures announced for extended-release and long-acting opioids. Updated 5 November 17; 2017 [cited 2017 Nov 1]; Available from: https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm363722.htm.
   Google Scholar
• United States Food and Drug Administration [Internet]. Silver Spring (MD): FDA. Labeling supplement and PMR required; 2017. [cited 2017 Nov 1]; Available from: https://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM367697.pdf.
   Google Scholar
• Coplan PM, Cepeda MS, Petronis KR, et al. Postmarketing studies program to assess the risks and benefits of long-term use of extended-release/long-acting opioids among chronic pain patients. Postgrad Med. 2020;132(1):44–51.
   PubMed Web of Science ®Google Scholar
• Federal Register [Internet]. Washington (DC): Federal Register. Postmarketing requirements for the class-wide extended-release/long-acting opioid analgesics; Public Meeting; Request for Comments; 2014. [cited 2017 Nov 1]; Available from: https://www.federalregister.gov/documents/2014/04/22/2014-09123/postmarketing-requirements-for-the-class-wide-extended-releaselong-acting-opioid-analgesics-public.
   Google Scholar
• Clinicaltrials.gov [Internet]. Bethesda (MD): U.S. National Library of Medicine. An observational study to develop algorithms for identifying opioid abuse and addiction based on admin claims data; 2017 [cited 2017 Nov 1]:[ClinicalTrials.gov identifier: NCT02667262]. Available from: https://clinicaltrials.gov/ct2/show/NCT02667262?term=Opioid+PMR+Consortium&draw=1&rank=5.
   Google Scholar
• Clinicaltrials.gov [Internet]. Bethesda (MD): U.S. National Library of Medicine. Incidence and predictors of opioid overdose and death in ER/LA opioid users as measured by diagnoses and death records; 2017 [cited 2017 Nov 1]; Available from: https://clinicaltrials.gov/ct2/show/NCT02662153?term=Opioid+PMR+Consortium&draw=1&rank=3.
   Google Scholar
• Yu S, Ma Y, Gronsbell J, et al. Enabling phenotypic big data with PheNorm. J Am Med Inform Assoc. 2018;25(1):54–60.
   PubMed Web of Science ®Google Scholar
• Kaur H, Sohn S, Wi CI, et al. Automated chart review utilizing natural language processing algorithm for asthma predictive index. BMC Pulm Med. 2018;18(1):34.
   PubMedGoogle Scholar
• Martin S, Wagner J, Lupulescu-Mann N, et al. Comparison of EHR-based diagnosis documentation locations to a gold standard for risk stratification in patients with multiple chronic conditions. Appl Clin Inform. 2017;08(03):794–809.
   Google Scholar
• Carrell DS, Albertson-Junkans L, Ramaprasan A, et al. Problem opioid use among patients receiving long-term opioid therapy established by manual chart review. 2020. (Under Review).
   Google Scholar
• Epic Systems Corporation. Verona (WI): Epic.; 1979 [cited 2014 Oct 6]; Available from: http://www.epic.com/.
   Google Scholar
• Curtis LH, Brown J, Platt R. Four health data networks illustrate the potential for a shared national multipurpose big-data network. Health Aff (Millwood). 2014;33(7):1178–1186.
   PubMed Web of Science ®Google Scholar
• United States Food and Drug Administration [Internet]. Silver Spring (MD): FDA. FDA’s sentinel initiative: transforming how we monitor the safety of FDA-regulated products; 2019 [cited 2012 Oct 29]; Available from: https://www.fda.gov/safety/fdas-sentinel-initiative.
   Google Scholar
• United States Food and Drug Administration [Internet]. Silver Spring (MD): FDA. Sentinel distributed database and common data model; 2017 [cited 2017 Jul 21]; Available from: https://www.sentinelinitiative.org/sentinel/data/distributed-database-common-data-model.
   Google Scholar
• Platt R, Wilson M, Chan KA, et al. The new Sentinel Network–improving the evidence of medical-product safety. N Engl J Med. 2009;361(7):645–647.
   PubMed Web of Science ®Google Scholar
• Edlund MJ, Steffick D, Hudson T, et al. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129:355–362.
   PubMed Web of Science ®Google Scholar
• Chou R, Fanciullo GJ, Fine PG, et al. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10(2):131–146.
   PubMed Web of Science ®Google Scholar
• Passik SD, Kirsh KL, Donaghy KB, et al. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain. 2006;22:173–181.
   PubMed Web of Science ®Google Scholar
• Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276–286.
   PubMed Web of Science ®Google Scholar
• Katz C, El-Gabalawy R, Keyes KM, et al. Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample. Drug Alcohol Depend. 2013;132(1–2):107–113.
   PubMed Web of Science ®Google Scholar
• Saha TD, Kerridge BT, Goldstein RB, et al. Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States. J Clin Psychiatry. 2016;77(06):772–780.
   PubMedGoogle Scholar
• Goldner EM, Lusted A, Roerecke M, et al. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses. Addict Behav. 2014;39(3):520–531.
   PubMed Web of Science ®Google Scholar
• Amari E, Rehm J, Goldner E, et al. Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review. Can J Psychiatry. 2011;56(8):495–502.
   PubMed Web of Science ®Google Scholar
• Tibshirani RJ. Regression shrinkage and selection via the lasso. J R Stat Soc Series B Stat Methodol. 1996;58:14.
   Google Scholar
• Hastie T, Tibshirani RJ, Freidman J. The elements of statistical learning. New York (NY): Springer; 2009.
   Google Scholar
• Ulbricht J. lqa: Penalized Likelihood Inference for GLMs, version 1.0-3. 2012. [updated 2012 Oct 29; cited 2017 Jul 21]; Available from: https://cran.r-project.org/web/packages/lqa/index.html.
   Google Scholar
• Zou H. The adaptive lasso and its oracle properties. J Am Stat Assoc. 2006;101:12.
   Web of Science ®Google Scholar
• Kim JK, Skinner CJ. Weighting in survey analysis under informative sampling. Biometrika. 2013;100(2):385–398.
   Web of Science ®Google Scholar
• Fuller W. Sampling statistics. Hoboken (NJ): Wiley; 2009.
   Google Scholar
• Chambers RL, Skinner CJ. Analysis of survey data. Chichester (UK): Wiley; 2003.
   Google Scholar
• Vertelney H, Yarger J, Tilley L, et al. Health insurance churning among young adults in California: by the numbers. San Francisco (CA): Phillip R. Lee Institute for Health Policy Studies; 2017 [cited 2017 November 1]; Available from: https://healthpolicy.ucsf.edu/health-insurance-churning-among-young-adults.
   Google Scholar
• Callahan ST, Cooper WO. Continuity of health insurance coverage among young adults with disabilities. Pediatrics. 2007;119(6):1175–1180.
   PubMed Web of Science ®Google Scholar
• Green CA, Perrin NA, Hazlehurst B, et al. Identifying and classifying opioid-related overdoses: a validation study. Pharmacoepidemiol Drug Saf. 2019;28(8):1127–1137.
   PubMed Web of Science ®Google Scholar
• Canan C, Polinski JM, Alexander GC, et al. Automatable algorithms to identify nonmedical opioid use using electronic data: a systematic review. J Am Med Inform Assoc. 2017;24(6):1204–1210.
   PubMed Web of Science ®Google Scholar
• Maxim LD, Niebo R, Utell MJ. Screening tests: a review with examples. Inhal Toxicol. 2014;26(13):811–828.
   PubMed Web of Science ®Google Scholar
• Smith DC, Bennett KM, Dennis ML, et al. Sensitivity and specificity of the gain short-screener for predicting substance use disorders in a large national sample of emerging adults. Addict Behav. 2017;68:14–17.
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Ellis MS, Kasper ZA. Relative preferences in the abuse of immediate-release versus extended-release opioids in a sample of treatment-seeking opioid abusers. Pharmacoepidemiol Drug Saf. 2017;26(1):56–62.
   PubMed Web of Science ®Google Scholar
• Juurlink DN, Dhalla IA. Dependence and addiction during chronic opioid therapy. J Med Toxicol. 2012;8(4):393–399.
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th (revised) ed. Arlington (VA): American Psychiatric Publishing; 2013.
   Google Scholar
• Smith SM, Dart RC, Katz NP, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154(11):2287–2296.
   PubMed Web of Science ®Google Scholar
• Vowles KE, McEntee ML, Siyahhan Julnes P, et al. On the importance of clear comparisons and a methodologically rigorous empirical literature in evaluating opioid use in chronic pain: a response to Scholten and Henningfield. Pain. 2015;156(8):1577–1578.
   PubMed Web of Science ®Google Scholar
• Nikulina V, Guarino H, Acosta MC, et al. Patient vs provider reports of aberrant medication-taking behavior among opioid-treated patients with chronic pain who report misusing opioid medication. Pain. 2016;157(8):1791–1798.
   PubMed Web of Science ®Google Scholar